Pelican Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8122 Datapoint Dr Ste 445, San Antonio, ...Phone Number
(919) 240-7133Website
www.pelicantherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Pelican Therapeutics
Pelican Therapeutics, Inc., a subsidiary of Heat, is focused on the development of therapies designed to activate the immune system. PTX-35 targets the T-cell co-stimulator, TNFRSF25, and is designed to harness natural immune mechanisms that may reprogram tumor immunity. When combined with immunotherapies, including Heat's T-cell Activation Platform (TCAP), PTX-35 may have the ability to boost antigen-specific T-cells and eliminate tumor cells in patients. In June 2016, Pelican was awarded a $15.2 million Cancer Prevention Institute of Texas (CPRIT) grant to support further development of PTX-35 and fund a Phase 1 clinical trial to examine potential benefits to patients with several types of cancers.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pelican Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pelican Therapeutics is spiking on competitors!
Check if Pelican Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Pelican Therapeutics had a recent Job posting/layoffs
Pelican Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pelican Therapeutics
Product Launch: Get notified when Pelican Therapeutics launches new products
Earning: See what the market has to say on Pelican Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Pelican Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Pelican Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Pelican Therapeutics
Compare insights from companies similar to Pelican Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pelican Therapeutics
<$5M
1-10
Private
-
2009
N/A
<$5M
11-50
Private
-
2005
RR
Richard RobbFounder & Vice President, Research, Development & Quality Assurance
Company Profile Activity
Activity Insights
Pelican Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pelican Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pelican Therapeutics.
Pelican Therapeutics Tech Stack
A closer look at the technologies used by Pelican Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pelican Therapeutics
Sign Up For FreeTo access detailed company insights
Pelican Therapeutics, Inc., a subsidiary of Heat, is focused on the development of therapies designed to activate the immune system. PTX-35 targets the T-cell co-stimulator, TNFRSF25, and is designed to harness natural immune mechanisms that may reprogram tumor immunity. When combined with immunotherapies, including Heat's T-cell Activation Platfor... Read More
